1,074
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials

, , , , , , , , , , & show all
Article: 2324833 | Received 11 Dec 2023, Accepted 23 Feb 2024, Published online: 12 May 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.